Altfest L J & CO Inc Incyte Corp Transaction History

Altfest L J & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$60.95 - $75.51 $220,456 - $273,119	3,617 New	3,617 $225,000
Q3 2021 Oct 12, 2021	SELL	$68.67 - $84.02 $296,448 - $362,714	-4,317 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$79.87 - $87.53 $74,918 - $82,103	938 Added 27.76%	4,317 $363,000
Q1 2021 May 07, 2021	BUY	$76.02 - $100.5 $3,344 - $4,422	44 Added 1.32%	3,379 $275,000
Q4 2020 Jan 21, 2021	BUY	$80.74 - $97.7 $269,267 - $325,829	3,335 New	3,335 $290,000
Q3 2018 Oct 10, 2018	SELL	$61.75 - $74.23 $592,923 - $712,756	-9,602 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$60.85 - $83.98 $2,616 - $3,611	-43 Reduced 0.45%	9,602 $643,000
Q1 2018 May 10, 2018	BUY	$83.06 - $100.98 $801,113 - $973,952	9,645 New	9,645 $804,000

659

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Altfest L J & CO Inc with notifications on news.